DEFA14A: Monro Defends Director Auerbach Amid Proxy Advisor Vote

Monro, Inc. urges shareholders to vote for director John Auerbach despite proxy advisor recommendations against his re-election due to attendance issues.

Summary

• Monro, Inc. will hold its 2025 Annual Meeting of Shareholders on August 12, 2025.
• The Board of Directors recommends a vote FOR the election of all 8 director nominees, including John Auerbach.
• Institutional Shareholder Services (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) have recommended that shareholders withhold their votes to re-elect John Auerbach.
• The proxy advisor recommendations stem from Mr. Auerbach's attendance of less than 75% of Board and committee meetings during Fiscal Year 2025 (Fiscal 2025).
• Mr. Auerbach attended 73% of Board and Compensation Committee meetings in Fiscal 2025.
• He missed two Board meetings and one Compensation Committee meeting in Fiscal 2025.
• A scriveners error in the 2025 Proxy Statement incorrectly reported Mr. Auerbach as having missed four meetings in total.
• The Board held six meetings and the Compensation Committee held five meetings in Fiscal 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the adverse recommendations from prominent proxy advisory firms, which could indicate a governance concern to some investors. However, the company is actively defending its position and providing detailed explanations, mitigating some of the negativity.

Positives

• Mr. Auerbach has consistently attended at least 75% of Board and Compensation Committee meetings since joining the Board in 2017, across 57 meetings from 2017-2024.
• His Fiscal 2025 attendance was an anomaly due to a serious medical issue in May 2024 and a previously scheduled work commitment in January 2025 for a special meeting called on short notice.
• If Mr. Auerbach had been able to attend the May 2024 Board and Committee meetings, his attendance for all Board and committee meetings would have been 91%.
• If the Compensation Committee meeting scheduled for March 27, 2025, had not been cancelled, Mr. Auerbach would have attended 75% of Board and committee meetings in Fiscal 2025.
• The Board believes Mr. Auerbach's absences were reasonable and understandable, aligning with Glass Lewis's and ISS's voting guidelines for medical illness and family emergencies.
• Mr. Auerbach is fully committed to the Board and the Company, understands the criticality of his attendance, and has confirmed his attendance will not be an issue going forward.
• He is an engaged and valued Board member, Chairperson of the Compensation Committee, and brings critical skillsets and expertise in technology, consumer, digital, retail, eCommerce deployment and strategy, brand building, digital marketing, and artificial intelligence.

Negatives

• Institutional Shareholder Services (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) recommended withholding votes for John Auerbach's re-election.
• Mr. Auerbach's reported attendance for Fiscal 2025 was 73%, falling below the 75% threshold often expected by proxy advisors.
• An initial scriveners error in the 2025 Proxy Statement incorrectly stated he missed four meetings, potentially contributing to proxy advisor concerns.

Risks

• Shareholders may follow proxy advisor recommendations, potentially leading to Mr. Auerbach's non-re-election.
• Loss of an 'extremely valuable' Board member with critical skillsets and expertise if Mr. Auerbach is not re-elected.
• Perception of corporate governance issues due to a director's attendance falling below standard thresholds, despite the company's explanations.

Future Outlook

Mr. Auerbach has confirmed that his attendance will not be an issue going forward. The Board expects that, absent a circumstance such as a medical or family emergency, directors will attend at least 75% of all Board and committee meetings.

Management Comments

• "The Board believes Mr. Auerbachs absences were reasonable and understandable under the circumstances."
• "We urge Glass Lewis and ISS to reconsider their voting recommendations and urge shareholders to vote FOR all our director nominees, including Mr. Auerbach."
• "The Board believes Mr. Auerbach is an extremely valuable member of Monros Board."
• "The Nominating and Corporate Responsibility Committee discussed Mr. Auerbachs attendance, and I, as chair of the Nominating Committee, have personally spoken to Mr. Auerbach, who understands that his attendance is critical to his continued service on the Board and has confirmed that his attendance will not be an issue going forward." (Robert E. Mellor, Chairman of the Board)

Industry Context

This filing highlights the significant influence of proxy advisory firms like ISS and Glass Lewis on corporate governance and shareholder voting decisions. Companies often issue supplemental proxy materials to counter negative recommendations, emphasizing the importance of director attendance and the value of specific board members.

Corporate Governance

Stakeholder Impact

• Shareholders are directly impacted by the voting decision on director re-election, influencing board composition and governance oversight.
• The Board of Directors' composition and stability are affected by the outcome, particularly regarding the continued service of a long-standing member and committee chair.
• Management works closely with the Board and its committees; the continuity of Board members like Mr. Auerbach impacts strategic and operational guidance.

Next Steps

• Shareholders to vote on director nominees at the Annual Meeting on August 12, 2025.
• Monro Board urges Glass Lewis and ISS to reconsider their recommendations.

Key Dates

Recommendation

The filing primarily addresses a corporate governance issue related to a director's attendance and proxy advisor recommendations, rather than financial performance or strategic shifts. While the negative recommendations from ISS and Glass Lewis could introduce some uncertainty, the company's detailed defense and the director's long-term commitment suggest this is a specific governance matter rather than a fundamental operational or financial concern that would warrant a strong buy or sell recommendation based solely on this filing. Investors should monitor the outcome of the vote and broader company performance.

Keywords

Monro, SEC filing, proxy statement, corporate governance, director election, John Auerbach, ISS, Glass Lewis, shareholder meeting, board attendance, compensation committee, retail, automotive services